General Health

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release

Retrieved on: 
Wednesday, June 29, 2022 - 9:15pm
Professional Services, Health, Other Professional Services, Other Health, Finance, General Health, Pharmaceutical, Health, Efficiency, AmerisourceBergen, New, Pharmacy, Solution, Company, Webcast, ABC, NYSE, Telephone, Fiscal, Online gambling

AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, prior to the opening of trading on the New York Stock Exchange.

Key Points: 
  • AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Third Quarter of Fiscal 2022 on Wednesday, August 3, 2022, prior to the opening of trading on the New York Stock Exchange.
  • Participating in the conference call will be:
    The live call will be webcast via the Companys website at investor.amerisourcebergen.com .
  • Users are encouraged to log on to the webcast approximately 10 minutes in advance of the scheduled start time of the call.
  • To access the call via telephone from within the United States and Canada, dial (844) 200-6205.

McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date

Retrieved on: 
Wednesday, June 29, 2022 - 9:10pm
Supply Chain Management, Medical Supplies, Retail, Health, Medical Devices, General Health, Pharmaceutical, Pharmacy, MCK, Patient, McKesson Corporation, NYSE, Public relations

McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022.

Key Points: 
  • McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022.
  • The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
  • The live webcast will be available on McKessons Investor Relations website at http://investor.mckesson.com , along with the companys earnings press release, financial tables and slide presentation.
  • McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.

Pfizer and BioNTech Announce New Agreement with U.S. Government to Provide Additional Doses of COVID-19 Vaccine

Retrieved on: 
Wednesday, June 29, 2022 - 9:45pm
Biotechnology, General Health, COVID-19, Health, Pharmaceutical, Emergency Use Authorization, Annual report, Science, Hoffmann-La Roche, LinkedIn, RNA transfection, Pfizer–BioNTech COVID-19 vaccine, Peer review, Research, DO, Marketing, COVID-19, Cancer, Company, U.S. Securities and Exchange Commission, Omicron, Regeneron Pharmaceuticals, Pierre Geneves, Awareness, Infection, Publication, Risk, YouTube, Clinical trial, Private Securities Litigation Reform Act, News, SEC, Facebook, BioNTech, Immunotherapy, Vaccine, Government, EUA, Safety, Twitter, Vaccination, Pediatrics, Program, BNT162, Genentech, Pfizer

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Key Points: 
  • Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
  • For more than 170 years, we have worked to make a difference for all who rely on us.
  • In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News , LinkedIn , YouTube and like us on Facebook at Facebook.com/Pfizer .
  • This press release contains forward-looking statements of BioNTech within the meaning of the Private Securities Litigation Reform Act of 1995.

Business Trade Fair Global Event is Coming to Minneapolis!

Retrieved on: 
Wednesday, June 29, 2022 - 8:46pm
Education, Other Health, Other Consumer, Organic Food, Digital Marketing, Consumer, Content Marketing, Other Construction & Property, Other Travel, Other Retail, Construction & Property, Other Communications, Travel, Other Transport, General Health, Health, Business, Communications, Transport, Other Technology, General Automotive, Catalog, Retail, Bridal, Finance, Consulting, Banking, Automotive, Technology, Professional Services, Other Energy, Other Manufacturing, Other Defense, Defense, Energy, Other Education, Insurance, Business, Invention, Government, Consultant, Emerging technologies, Marketing, Minneapolis Convention Center, Minneapolis, Time, Professional services, Information technology, Education, Video game

Business Trade Fair Global will hold a BIG Trade Fair event for the first time at the Minneapolis Convention Center on October 1st, 2022, featuring leading companies from the top industries to aspiring Small Businesses across the globe.

Key Points: 
  • Business Trade Fair Global will hold a BIG Trade Fair event for the first time at the Minneapolis Convention Center on October 1st, 2022, featuring leading companies from the top industries to aspiring Small Businesses across the globe.
  • The Business Trade Fair event will take place at the Minneapolis Convention Center, located at 1301 Second Avenue South, Minneapolis, MN 55403, and will be open to the public from 9:30 am until 6:30 pm.
  • Business Trade Fair Global is an international group that gets small, medium, or big size business in the eyes of consumers in large metropolitan areas and regions by hosting and sponsoring large trade fair events and expos.
  • Make sure your business participates by registering for this event as soon as possible before time and space run out.

Duality Quantum Accelerator Announces Startups Selected for Cohort 2

Retrieved on: 
Wednesday, June 29, 2022 - 8:07pm
Technology, General Health, Science, Health, Semiconductor, Security, Other Science, Chemicals, Plastics, Research, Nanotechnology, University, Manufacturing, Software, Networks, Education, Internet, Hardware, Research Park at the University of Illinois Urbana-Champaign, Science, Business, Research, Argonne National Laboratory, Engineering, U.S. Department of Defense Strategy for Operating in Cyberspace, Hotbed, Growth, Entrepreneurship, Intellectual property, University of Chicago Booth School of Business, Private sector, Innovation, Technology, University, CQE, P33, Mentorship, Globe, Leadership, Chicago (franchise), Program, Management, Video game, Duality

Duality, the nations first accelerator exclusively for quantum companies, has accepted five startups from across the globe into the second cohort of the year-long accelerator based in Chicago, IL.

Key Points: 
  • Duality, the nations first accelerator exclusively for quantum companies, has accepted five startups from across the globe into the second cohort of the year-long accelerator based in Chicago, IL.
  • Quantum will be the defining feature of the 21st centurys technological advancements, and Ive directed $200 million in state funding to facilitate Illinois global leadership in the quantum race.
  • Launched in April 2021 , Duality is a first-of-its-kind accelerator aimed at supporting next-generation startups focused on quantum science and technology.
  • Our scientific leadership is providing early-stage startups the expertise and facilities they need to bring transformative quantum innovations to market.

Ligand Pharmaceuticals Appoints Jason Haas to its Board of Directors

Retrieved on: 
Wednesday, June 29, 2022 - 9:01pm
Health, General Health, Research, Pharmaceutical, Science, Biotechnology, Board of directors, Gilead Sciences, International relations, Deutsche Bank, Economics, Company, Barclays, CFO, Merck, Colgate University, Therapy, Janssen, Syros, Baxter International, Nasdaq, Sanofi, Goldman Sachs, NASDAQ, Solubility, Amgen, Board, Twitter, Drug discovery, Columbia Business School, Ligand, Takeda, Pfizer

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (Ligand or the Company) announces the appointment of Jason Haas to the Company's Board of Directors.

Key Points: 
  • Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (Ligand or the Company) announces the appointment of Jason Haas to the Company's Board of Directors.
  • Mr. Haas brings more than 30 years of healthcare investment banking and corporate finance experience to Ligand.
  • Jason is a particularly opportune addition as we begin to reformulate the Ligand Board following the upcoming spin-off of OmniAb.
  • We welcome Jason to Ligands Board of Directors with delight and look forward to him adding to his already impressive legacy of benchmark transactions to Ligands business.

Zillion Earns 2022 Great Place to Work Certification™

Retrieved on: 
Wednesday, June 29, 2022 - 6:48pm
Technology, Health, Human Resources, Apps, Applications, Professional Services, Telemedicine, Virtual Medicine, Software, Managed Care, Networks, General Health, Internet, Health Technology, Health Insurance, Data Management, LinkedIn, Feedback, COVID-19, Trial balance, Great Places, Certification, Technology, Organization, Culture, Workplace, Place, Management, Public relations, Indefinite and fictitious numbers

This year, 94% of employees said its a great place to work 37 points higher than the average U.S. company.

Key Points: 
  • This year, 94% of employees said its a great place to work 37 points higher than the average U.S. company.
  • Great Place to Work Certification isnt something that comes easily it takes ongoing dedication to the employee experience, said Sarah Lewis-Kulin, Vice President of Global Recognition at Great Place to Work.
  • According to Great Place to Work research , job seekers are 4.5 times more likely to find a great boss at a Certified great workplace.
  • Great Place to Work Certification is the most definitive employer-of-choice recognition that companies aspire to achieve.

Global Wearable Patch Market Research Report to 2027 - Increasing Telehealth Adoption Across the Globe Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022 - 5:18pm
Health, Medical Devices, Diabetes, Telemedicine, Virtual Medicine, General Health, Pharmaceutical, Biotechnology, Acquisition, Decision-making, USD, Strategic management, Market share analysis, Value, R, Business Growth Fund, COVID-19, Customer support, Growth, Investment, Certification, CAGR, Technology, Use, Retail, Adhesive

Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Patch Market?

Key Points: 
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Wearable Patch Market?
  • What is the competitive strategic window for opportunities in the Global Wearable Patch Market?
  • What is the market share of the leading vendors in the Global Wearable Patch Market?
  • What modes and strategic moves are considered suitable for entering the Global Wearable Patch Market?

Global Blood Group Typing Market Analysis to 2029 - Featuring Ortho Clinical Diagnostics, Quotient, Novacyt and Rapid Labs Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 29, 2022 - 5:13pm
Health, General Health, Biotechnology, Conditional sentence, Laboratory, Accident, Forensic Science Service, Organ transplantation, Trauma, CAGR, ABO, HLA, Incidence, PCR, Government, Knowledge, Income, Vaccine, Fine chemical, Growth

Growth in global number of road accidents and trauma cases requiring blood transfusions is a key driver for the growth of the global blood group typing market.

Key Points: 
  • Growth in global number of road accidents and trauma cases requiring blood transfusions is a key driver for the growth of the global blood group typing market.
  • Additionally, increase in demand for blood group typing in prenatal testing and rise in application of blood group typing in forensic sciences are some of the other drivers propelling the market growth.
  • Nevertheless, high cost of blood group typing and lack of knowledge regarding blood group typing among developing economies are expected to restrain the global market growth.
  • Based on test type, the market is categorized into ABO blood tests, antibody screening, HLA typing, antigen typing, and cross-matching tests.

Exicure, Inc. Announces Receipt of Nasdaq Notice of Non-compliance and Implementation of One-for-Thirty Reverse Stock Split

Retrieved on: 
Wednesday, June 29, 2022 - 5:00pm
Research, Genetics, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Other Science, Science, Transfer, EDT, Panel, BID, Hearing, COVID-19, Ownership, Company, Bangladesh Securities and Exchange Commission, Forward-looking statement, Lists of diseases, Neuroscience, Compliance, CUSIP, Risk, LLC, AST, Hair loss, Private Securities Litigation Reform Act, RNA, SEC, NASDAQ, Time, Drug development, Security (finance), Auction, Audit, Nasdaq

The Company is implementing the reverse stock split in an effort to regain compliance with Nasdaqs minimum bid price requirement of $1.00 per share.

Key Points: 
  • The Company is implementing the reverse stock split in an effort to regain compliance with Nasdaqs minimum bid price requirement of $1.00 per share.
  • As a result of the reverse stock split, every thirty pre-split shares of common stock outstanding will be automatically combined and converted into one issued and outstanding share of common stock, without any change in the par value per share.
  • No fractional shares of the Companys common stock will be issued to any stockholders in connection with the reverse stock split.
  • Stockholders of record will receive information regarding their share ownership from the Companys transfer agent, American Stock Transfer & Trust Company, LLC.